Use of a Statistical Adaptive Treatment Strategy Approach for Emulating Randomized Controlled Trials Using Observational Data: The Example of Blood-Pressure Control Strategies for the Prevention of Cardiovascular Events Among Individuals With Hypertension at High Cardiovascular Risk

医学 观察研究 血压 随机对照试验 重症监护医学 内科学
作者
Tianze Jiao,Robert W. Platt,Antonios Douros,Kristian B. Filion
出处
期刊:American Journal of Epidemiology [Oxford University Press]
卷期号:192 (9): 1576-1591 被引量:1
标识
DOI:10.1093/aje/kwad091
摘要

Statistical approaches to adaptive treatment strategies (ATS) can be used to mimic the sequential decision-making inherently found in clinical practice. To illustrate the use of a statistical ATS approach, we emulated a target trial of different blood pressure (BP) control plans for the prevention of cardiovascular events among individuals with hypertension at high cardiovascular risk, inspired by the Systolic Blood Pressure Intervention Trial (SPRINT). We included 103,708 patients with hypertension and a "QRISK3" estimated 10-year risk of cardiovascular disease of ≥20% who initiated an antihypertensive drug between 1998 and 2018. Dynamic marginal structural models estimated the comparative effects of treating patients with intensive (target BP: 130/80 mm Hg), standard (140/90 mm Hg), and conservative (150/90 mm Hg) BP control strategies. The adjusted hazard ratios (HRs) for the intensive versus standard strategy were 0.96 (95% confidence interval (CI): 0.92, 1.00) for major adverse cardiovascular events and 0.93 (95% CI: 0.88, 0.97) for death from cardiovascular causes. For the conservative versus standard strategy, they were 1.06 (95% CI: 1.02, 1.10) and 1.08 (95% CI: 1.03, 1.13), respectively. These results are largely compatible with SPRINT. ATS can be used to emulate randomized controlled trials of complex treatment strategies in an observational setting and represents an alternative approach for situations where randomized controlled trials are not feasible.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
芳菲依旧应助临河盗龙采纳,获得50
刚刚
Redback完成签到,获得积分10
刚刚
科研小怪兽应助帆帆帆采纳,获得30
1秒前
会飞的猪完成签到,获得积分10
1秒前
2秒前
jingwen完成签到,获得积分10
2秒前
2秒前
2秒前
淡然老太完成签到,获得积分10
2秒前
一一完成签到,获得积分10
3秒前
雪山飞龙发布了新的文献求助10
3秒前
赘婿应助123采纳,获得10
3秒前
量子星尘发布了新的文献求助10
4秒前
Irena完成签到,获得积分10
5秒前
Ansong完成签到,获得积分10
5秒前
5秒前
Jasper应助许启帆采纳,获得10
6秒前
温柔的大蒜完成签到 ,获得积分20
6秒前
精明玲完成签到 ,获得积分10
6秒前
回忆完成签到,获得积分10
6秒前
顺鑫完成签到 ,获得积分10
7秒前
咯咯葛完成签到 ,获得积分10
7秒前
HJJHJH发布了新的文献求助10
7秒前
青山完成签到,获得积分10
8秒前
学术小白完成签到 ,获得积分10
8秒前
量子星尘发布了新的文献求助10
9秒前
9秒前
风吹草动玉米粒完成签到,获得积分10
9秒前
ding应助饱满的荧采纳,获得10
9秒前
SDLC完成签到,获得积分10
10秒前
杀出个黎明举报sanyuan求助涉嫌违规
11秒前
DTL哈哈完成签到 ,获得积分10
11秒前
大Doctor陈发布了新的文献求助10
12秒前
xuexue完成签到,获得积分10
12秒前
chen发布了新的文献求助10
12秒前
熬夜波比应助动听善斓采纳,获得10
12秒前
碧蓝世界完成签到 ,获得积分10
13秒前
Yangyang完成签到,获得积分10
13秒前
若槻椋完成签到,获得积分10
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Binary Alloy Phase Diagrams, 2nd Edition 8000
Building Quantum Computers 800
Translanguaging in Action in English-Medium Classrooms: A Resource Book for Teachers 700
Natural Product Extraction: Principles and Applications 500
Exosomes Pipeline Insight, 2025 500
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5664885
求助须知:如何正确求助?哪些是违规求助? 4872325
关于积分的说明 15109450
捐赠科研通 4823740
什么是DOI,文献DOI怎么找? 2582524
邀请新用户注册赠送积分活动 1536489
关于科研通互助平台的介绍 1495074